Latest Breaking News On - Mundipharma medical company mmco - Page 1 : comparemela.com

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRepublic of chinaTaiwan generalUnited kingdomHong kongJuventa inaticabtagene autoleucelRui zhangInaticabtagene autoleucelPharmaceuticals china co ltdAcrotech biopharma incMundipharma international corporation limitedChina national medical products administrationEuropean medicines agencyMundipharma medical company mmcoDrug administrationPharmaceuticals wuxi co ltd

Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals

/PRNewswire/ CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and.

United statesRui zhangAsia pacificAshish anvekarAcrotech biopharmaPharmaceuticals incMundipharma international corporation limitedNational medical products administrationEuropean medicines agencyAcrotech biopharma incChina national medical products administrationDrug administrationPharmaceuticals china co ltdMundipharma medical company mmcoPharmaceuticals wuxi co ltdExchange commission